Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Joon Seong Ahn, Ja Ryong Jeon, Hong Seok Yoo, Taek Kyu Park, Cheol Keun Park, Dong Hyun Sinn, Seung Woon Paik

Clin Mol Hepatol. 2013;19(2):173-178. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.173

View: 7724 Download: 69 Crossref: 8

Jae Myeong Jo, Jin Woong Kim, Suk Hee Heo, Sang Soo Shin, Yong Yeon Jeong, Young Hoe Hur

Clin Mol Hepatol. 2012;18(4):420-423. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.420

View: 6759 Download: 98 Crossref: 9

Eun Hyoung Jeong, M.D., Dong Hyun Kim, M.D., Sung Ho Ma, M.D., Eui Jong Chung, M.D., Sang Su Bae, M.D., A Young Park, M.D. Hyung Jun Chu, M.D.

Clin Mol Hepatol. 2009;15(2):201-208. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.201

View: 4667 Download: 49 Crossref: 2

1 |

Viewed By 5365	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5325	MAFLD: How is it different from NAFLD?
Viewed By 5212	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3895	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3858	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search